Raymond James & Associates Trinity Biotech PLC Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$5.08 - $6.06 $73,802 - $88,039	-14,528 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.5 - $5.77 $81,144 - $104,044	-18,032 Reduced 55.38%	14,528 $74,000
Q3 2017 Nov 13, 2017	BUY	$5.16 - $5.67 $38,715 - $42,542	7,503 Added 29.94%	32,560 $183,000
Q2 2017 Aug 14, 2017	BUY	N/A	25,057	25,057 $150,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $46.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.